PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PTC Therapeutics Inc
Other Long-Term Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Other Long-Term Assets
$23.1m
CAGR 3-Years
-31%
CAGR 5-Years
32%
CAGR 10-Years
40%
Abbvie Inc
NYSE:ABBV
Other Long-Term Assets
$9.2B
CAGR 3-Years
24%
CAGR 5-Years
50%
CAGR 10-Years
28%
Gilead Sciences Inc
NASDAQ:GILD
Other Long-Term Assets
$4.4B
CAGR 3-Years
-8%
CAGR 5-Years
13%
CAGR 10-Years
18%
Amgen Inc
NASDAQ:AMGN
Other Long-Term Assets
$8.8B
CAGR 3-Years
15%
CAGR 5-Years
37%
CAGR 10-Years
19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Long-Term Assets
$3B
CAGR 3-Years
44%
CAGR 5-Years
15%
CAGR 10-Years
79%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Long-Term Assets
$3.9B
CAGR 3-Years
66%
CAGR 5-Years
32%
CAGR 10-Years
30%

See Also

What is PTC Therapeutics Inc's Other Long-Term Assets?
Other Long-Term Assets
23.1m USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Other Long-Term Assets amounts to 23.1m USD.

What is PTC Therapeutics Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
40%

Over the last year, the Other Long-Term Assets growth was -35%. The average annual Other Long-Term Assets growth rates for PTC Therapeutics Inc have been -31% over the past three years , 32% over the past five years , and 40% over the past ten years .

Back to Top